MedPage Today on MSN
Are Bayesian statistics coming to a clinical trial near you?
What physicians should know about FDA's new proposed guidance ...
Moving Beyond Basic AI Adoption, PhaseV Will Demonstrate How Causal AI/ML Achieves Significant Improvements in Trial Design, Execution and Patient Outcomes BOSTON, March 26, 2026 /PRNewswire/ -- ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
POMPANO BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal ...
The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
Benefit of adding Cureety remote patient monitoring (RPM) to usual care during injectable anticancer treatment: The OPTIMACURE multicentric French prospective randomized study. This is an ASCO Meeting ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
Navigating today’s rapidly evolving clinical trial landscape can be tough. With intricate protocols and shifting regulatory demands, it’s more difficult than ever to find and keep participants, as ...
Bayesian statistics represents a powerful framework for data analysis that centres on Bayes’ theorem, enabling researchers to update existing beliefs with incoming evidence. By combining prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results